Arrayit Corporation
Arrayit Corporation ARYC Peers
See (ARYC) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ARYC | $0.00 | +0.00% | 79348.00 | N/A | N/A | N/A |
| LZAGY | $68.21 | -3.30% | 49.20B | 63.15 | $1.08 | +0.64% |
| LZAGF | $690.05 | -2.98% | 48.53B | 63.78 | $10.82 | +0.65% |
| WUXAY | $7.86 | +3.10% | 24.17B | 14.83 | $0.53 | +3.55% |
| WUXIF | $7.34 | N/A | 21.28B | 13.85 | $0.53 | +1.89% |
| BMXMF | $128.95 | N/A | 15.21B | 31.37 | $4.11 | +0.72% |
| ERFSF | $60.97 | -1.72% | 10.73B | 25.83 | $2.36 | +1.81% |
| SKHHY | $16.04 | -0.12% | 7.70B | 22.59 | $0.71 | +3.96% |
| SKHCF | $14.80 | N/A | 7.11B | 20.56 | $0.72 | +3.84% |
| DSRLF | $104.69 | -2.82% | 5.64B | 27.55 | $3.80 | +1.22% |
Stock Comparison
ARYC vs LZAGY Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, LZAGY has a market cap of 49.20B. Regarding current trading prices, ARYC is priced at $0.00, while LZAGY trades at $68.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas LZAGY's P/E ratio is 63.15. In terms of profitability, ARYC's ROE is +0.55%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, ARYC is more volatile compared to LZAGY. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs LZAGF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, LZAGF has a market cap of 48.53B. Regarding current trading prices, ARYC is priced at $0.00, while LZAGF trades at $690.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas LZAGF's P/E ratio is 63.78. In terms of profitability, ARYC's ROE is +0.55%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, ARYC is more volatile compared to LZAGF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs WUXAY Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, WUXAY has a market cap of 24.17B. Regarding current trading prices, ARYC is priced at $0.00, while WUXAY trades at $7.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas WUXAY's P/E ratio is 14.83. In terms of profitability, ARYC's ROE is +0.55%, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, ARYC is more volatile compared to WUXAY. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs WUXIF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, WUXIF has a market cap of 21.28B. Regarding current trading prices, ARYC is priced at $0.00, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas WUXIF's P/E ratio is 13.85. In terms of profitability, ARYC's ROE is +0.55%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, ARYC is more volatile compared to WUXIF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs BMXMF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, BMXMF has a market cap of 15.21B. Regarding current trading prices, ARYC is priced at $0.00, while BMXMF trades at $128.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas BMXMF's P/E ratio is 31.37. In terms of profitability, ARYC's ROE is +0.55%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, ARYC is more volatile compared to BMXMF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs ERFSF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, ERFSF has a market cap of 10.73B. Regarding current trading prices, ARYC is priced at $0.00, while ERFSF trades at $60.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas ERFSF's P/E ratio is 25.83. In terms of profitability, ARYC's ROE is +0.55%, compared to ERFSF's ROE of +0.07%. Regarding short-term risk, ARYC is more volatile compared to ERFSF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs SKHHY Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, SKHHY has a market cap of 7.70B. Regarding current trading prices, ARYC is priced at $0.00, while SKHHY trades at $16.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas SKHHY's P/E ratio is 22.59. In terms of profitability, ARYC's ROE is +0.55%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, ARYC is more volatile compared to SKHHY. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs SKHCF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, SKHCF has a market cap of 7.11B. Regarding current trading prices, ARYC is priced at $0.00, while SKHCF trades at $14.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas SKHCF's P/E ratio is 20.56. In terms of profitability, ARYC's ROE is +0.55%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, ARYC is more volatile compared to SKHCF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs DSRLF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, DSRLF has a market cap of 5.64B. Regarding current trading prices, ARYC is priced at $0.00, while DSRLF trades at $104.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas DSRLF's P/E ratio is 27.55. In terms of profitability, ARYC's ROE is +0.55%, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, ARYC is more volatile compared to DSRLF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs HNGZY Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, HNGZY has a market cap of 4.48B. Regarding current trading prices, ARYC is priced at $0.00, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, ARYC's ROE is +0.55%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, ARYC is more volatile compared to HNGZY. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs VIMGF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, VIMGF has a market cap of 1.81B. Regarding current trading prices, ARYC is priced at $0.00, while VIMGF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas VIMGF's P/E ratio is 70.00. In terms of profitability, ARYC's ROE is +0.55%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, ARYC is more volatile compared to VIMGF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs MRCHF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, MRCHF has a market cap of 962.56M. Regarding current trading prices, ARYC is priced at $0.00, while MRCHF trades at $16.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas MRCHF's P/E ratio is -99.65. In terms of profitability, ARYC's ROE is +0.55%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, ARYC is more volatile compared to MRCHF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs IDGXF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, IDGXF has a market cap of 186.02M. Regarding current trading prices, ARYC is priced at $0.00, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, ARYC's ROE is +0.55%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, ARYC is more volatile compared to IDGXF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs ATLN Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, ATLN has a market cap of 186.00M. Regarding current trading prices, ARYC is priced at $0.00, while ATLN trades at $2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas ATLN's P/E ratio is -0.81. In terms of profitability, ARYC's ROE is +0.55%, compared to ATLN's ROE of -19.68%. Regarding short-term risk, ARYC is more volatile compared to ATLN. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs EDTXF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, EDTXF has a market cap of 174.08M. Regarding current trading prices, ARYC is priced at $0.00, while EDTXF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas EDTXF's P/E ratio is -15.26. In terms of profitability, ARYC's ROE is +0.55%, compared to EDTXF's ROE of +0.61%. Regarding short-term risk, ARYC is more volatile compared to EDTXF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs AMCY Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, AMCY has a market cap of 171.27M. Regarding current trading prices, ARYC is priced at $0.00, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas AMCY's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to AMCY's ROE of N/A. Regarding short-term risk, ARYC is more volatile compared to AMCY. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs NNGRF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, NNGRF has a market cap of 164.30M. Regarding current trading prices, ARYC is priced at $0.00, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, ARYC's ROE is +0.55%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, ARYC is more volatile compared to NNGRF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs CORBF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, CORBF has a market cap of 140.61M. Regarding current trading prices, ARYC is priced at $0.00, while CORBF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas CORBF's P/E ratio is 2.92. In terms of profitability, ARYC's ROE is +0.55%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, ARYC is more volatile compared to CORBF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs THOXF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, THOXF has a market cap of 130.94M. Regarding current trading prices, ARYC is priced at $0.00, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas THOXF's P/E ratio is -14.40. In terms of profitability, ARYC's ROE is +0.55%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, ARYC is more volatile compared to THOXF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs DIUXF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, DIUXF has a market cap of 115.49M. Regarding current trading prices, ARYC is priced at $0.00, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, ARYC's ROE is +0.55%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, ARYC is more volatile compared to DIUXF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs ANPCF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, ANPCF has a market cap of 99.98M. Regarding current trading prices, ARYC is priced at $0.00, while ANPCF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas ANPCF's P/E ratio is -3.10. In terms of profitability, ARYC's ROE is +0.55%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, ARYC is more volatile compared to ANPCF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs TIHE Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, TIHE has a market cap of 71.85M. Regarding current trading prices, ARYC is priced at $0.00, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas TIHE's P/E ratio is 0.32. In terms of profitability, ARYC's ROE is +0.55%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, ARYC is more volatile compared to TIHE. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs BIOGF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, BIOGF has a market cap of 65.41M. Regarding current trading prices, ARYC is priced at $0.00, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, ARYC's ROE is +0.55%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, ARYC is more volatile compared to BIOGF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs PCNEF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, PCNEF has a market cap of 63.00M. Regarding current trading prices, ARYC is priced at $0.00, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, ARYC's ROE is +0.55%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, ARYC is more volatile compared to PCNEF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs PFGTF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, PFGTF has a market cap of 50.58M. Regarding current trading prices, ARYC is priced at $0.00, while PFGTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas PFGTF's P/E ratio is -3.11. In terms of profitability, ARYC's ROE is +0.55%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, ARYC is more volatile compared to PFGTF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs BIOQ Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, BIOQ has a market cap of 42.46M. Regarding current trading prices, ARYC is priced at $0.00, while BIOQ trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas BIOQ's P/E ratio is 13.69. In terms of profitability, ARYC's ROE is +0.55%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, ARYC is more volatile compared to BIOQ. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs CLIFF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, CLIFF has a market cap of 29.65M. Regarding current trading prices, ARYC is priced at $0.00, while CLIFF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas CLIFF's P/E ratio is -1.93. In terms of profitability, ARYC's ROE is +0.55%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, ARYC is more volatile compared to CLIFF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs ANPCY Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, ANPCY has a market cap of 27.08M. Regarding current trading prices, ARYC is priced at $0.00, while ANPCY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas ANPCY's P/E ratio is -0.92. In terms of profitability, ARYC's ROE is +0.55%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, ARYC is more volatile compared to ANPCY. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs SNANF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, SNANF has a market cap of 25.05M. Regarding current trading prices, ARYC is priced at $0.00, while SNANF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas SNANF's P/E ratio is -11.56. In terms of profitability, ARYC's ROE is +0.55%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, ARYC is more volatile compared to SNANF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs PMSNF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, PMSNF has a market cap of 23.61M. Regarding current trading prices, ARYC is priced at $0.00, while PMSNF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas PMSNF's P/E ratio is -4.00. In terms of profitability, ARYC's ROE is +0.55%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, ARYC is more volatile compared to PMSNF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs VILGF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, VILGF has a market cap of 20.67M. Regarding current trading prices, ARYC is priced at $0.00, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas VILGF's P/E ratio is -0.30. In terms of profitability, ARYC's ROE is +0.55%, compared to VILGF's ROE of N/A. Regarding short-term risk, ARYC is more volatile compared to VILGF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs IMMVF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, IMMVF has a market cap of 19.33M. Regarding current trading prices, ARYC is priced at $0.00, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, ARYC's ROE is +0.55%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, ARYC is more volatile compared to IMMVF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs LDXHF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, LDXHF has a market cap of 18.71M. Regarding current trading prices, ARYC is priced at $0.00, while LDXHF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas LDXHF's P/E ratio is -2.50. In terms of profitability, ARYC's ROE is +0.55%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, ARYC is more volatile compared to LDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs PCHM Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, PCHM has a market cap of 18.44M. Regarding current trading prices, ARYC is priced at $0.00, while PCHM trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas PCHM's P/E ratio is -0.02. In terms of profitability, ARYC's ROE is +0.55%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, ARYC is more volatile compared to PCHM. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs BMKDF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, BMKDF has a market cap of 15.45M. Regarding current trading prices, ARYC is priced at $0.00, while BMKDF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas BMKDF's P/E ratio is -17.00. In terms of profitability, ARYC's ROE is +0.55%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, ARYC is more volatile compared to BMKDF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs ABDXF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, ABDXF has a market cap of 13.55M. Regarding current trading prices, ARYC is priced at $0.00, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, ARYC's ROE is +0.55%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, ARYC is more volatile compared to ABDXF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs IZOZF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, IZOZF has a market cap of 12.11M. Regarding current trading prices, ARYC is priced at $0.00, while IZOZF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas IZOZF's P/E ratio is -6.67. In terms of profitability, ARYC's ROE is +0.55%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, ARYC is more volatile compared to IZOZF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs MXDHF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, MXDHF has a market cap of 8.65M. Regarding current trading prices, ARYC is priced at $0.00, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, ARYC's ROE is +0.55%, compared to MXDHF's ROE of -6.91%. Regarding short-term risk, ARYC is more volatile compared to MXDHF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs VRCDF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, VRCDF has a market cap of 7.28M. Regarding current trading prices, ARYC is priced at $0.00, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, ARYC's ROE is +0.55%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, ARYC is more volatile compared to VRCDF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs TDSGF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, TDSGF has a market cap of 7.09M. Regarding current trading prices, ARYC is priced at $0.00, while TDSGF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas TDSGF's P/E ratio is -2.37. In terms of profitability, ARYC's ROE is +0.55%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, ARYC is more volatile compared to TDSGF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs SQIDF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, SQIDF has a market cap of 6.07M. Regarding current trading prices, ARYC is priced at $0.00, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, ARYC's ROE is +0.55%, compared to SQIDF's ROE of +0.00%. Regarding short-term risk, ARYC is more volatile compared to SQIDF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs GNTLF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, GNTLF has a market cap of 6.05M. Regarding current trading prices, ARYC is priced at $0.00, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, ARYC's ROE is +0.55%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, ARYC is more volatile compared to GNTLF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs SLDX Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, SLDX has a market cap of 4.78M. Regarding current trading prices, ARYC is priced at $0.00, while SLDX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas SLDX's P/E ratio is -0.01. In terms of profitability, ARYC's ROE is +0.55%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, ARYC is more volatile compared to SLDX. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs RNVA Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, RNVA has a market cap of 4.31M. Regarding current trading prices, ARYC is priced at $0.00, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas RNVA's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, ARYC is more volatile compared to RNVA. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs JMPHF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, JMPHF has a market cap of 4.15M. Regarding current trading prices, ARYC is priced at $0.00, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, ARYC's ROE is +0.55%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, ARYC is more volatile compared to JMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs AVCRF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, AVCRF has a market cap of 3.78M. Regarding current trading prices, ARYC is priced at $0.00, while AVCRF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas AVCRF's P/E ratio is -3.73. In terms of profitability, ARYC's ROE is +0.55%, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, ARYC is more volatile compared to AVCRF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs IDXG Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, IDXG has a market cap of 3.58M. Regarding current trading prices, ARYC is priced at $0.00, while IDXG trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas IDXG's P/E ratio is 1.98. In terms of profitability, ARYC's ROE is +0.55%, compared to IDXG's ROE of -0.66%. Regarding short-term risk, ARYC is more volatile compared to IDXG. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs SZLSF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, SZLSF has a market cap of 3.55M. Regarding current trading prices, ARYC is priced at $0.00, while SZLSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas SZLSF's P/E ratio is -0.02. In terms of profitability, ARYC's ROE is +0.55%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, ARYC is more volatile compared to SZLSF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs IDTA Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, IDTA has a market cap of 3.03M. Regarding current trading prices, ARYC is priced at $0.00, while IDTA trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas IDTA's P/E ratio is 7.50. In terms of profitability, ARYC's ROE is +0.55%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, ARYC is more volatile compared to IDTA. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs ICBU Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, ICBU has a market cap of 2.26M. Regarding current trading prices, ARYC is priced at $0.00, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas ICBU's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, ARYC is more volatile compared to ICBU. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs RSHN Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, RSHN has a market cap of 1.63M. Regarding current trading prices, ARYC is priced at $0.00, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas RSHN's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, ARYC is more volatile compared to RSHN. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs IBXXF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, IBXXF has a market cap of 1.61M. Regarding current trading prices, ARYC is priced at $0.00, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas IBXXF's P/E ratio is -0.27. In terms of profitability, ARYC's ROE is +0.55%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, ARYC is more volatile compared to IBXXF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs IVRO Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, IVRO has a market cap of 1.28M. Regarding current trading prices, ARYC is priced at $0.00, while IVRO trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas IVRO's P/E ratio is -0.70. In terms of profitability, ARYC's ROE is +0.55%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, ARYC is more volatile compared to IVRO. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs DIGP Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, DIGP has a market cap of 1.09M. Regarding current trading prices, ARYC is priced at $0.00, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas DIGP's P/E ratio is -1.04. In terms of profitability, ARYC's ROE is +0.55%, compared to DIGP's ROE of +0.05%. Regarding short-term risk, ARYC is more volatile compared to DIGP. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs SCRSF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, SCRSF has a market cap of 849801.00. Regarding current trading prices, ARYC is priced at $0.00, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, ARYC's ROE is +0.55%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, ARYC is more volatile compared to SCRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs EPGNF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, EPGNF has a market cap of 692790.00. Regarding current trading prices, ARYC is priced at $0.00, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, ARYC's ROE is +0.55%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, ARYC is more volatile compared to EPGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs NSTM Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, NSTM has a market cap of 468815.00. Regarding current trading prices, ARYC is priced at $0.00, while NSTM trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas NSTM's P/E ratio is -0.14. In terms of profitability, ARYC's ROE is +0.55%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, ARYC is more volatile compared to NSTM. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs MBGNF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, MBGNF has a market cap of 172578.00. Regarding current trading prices, ARYC is priced at $0.00, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, ARYC's ROE is +0.55%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, ARYC is more volatile compared to MBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs NVTAQ Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, NVTAQ has a market cap of 85948.00. Regarding current trading prices, ARYC is priced at $0.00, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, ARYC's ROE is +0.55%, compared to NVTAQ's ROE of +1.79%. Regarding short-term risk, ARYC is more volatile compared to NVTAQ. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs HCLC Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, HCLC has a market cap of 73985.00. Regarding current trading prices, ARYC is priced at $0.00, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas HCLC's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, ARYC is more volatile compared to HCLC. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs MEDVF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, MEDVF has a market cap of 54038.00. Regarding current trading prices, ARYC is priced at $0.00, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, ARYC's ROE is +0.55%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, ARYC is more volatile compared to MEDVF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs CHHL Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, CHHL has a market cap of 37320.00. Regarding current trading prices, ARYC is priced at $0.00, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas CHHL's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to CHHL's ROE of N/A. Regarding short-term risk, ARYC is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for ARYC.
ARYC vs IHTI Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, IHTI has a market cap of 32514.00. Regarding current trading prices, ARYC is priced at $0.00, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas IHTI's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, ARYC is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for ARYC.
ARYC vs MEDD Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, MEDD has a market cap of 31910.00. Regarding current trading prices, ARYC is priced at $0.00, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas MEDD's P/E ratio is -0.01. In terms of profitability, ARYC's ROE is +0.55%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, ARYC is more volatile compared to MEDD. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs CGNH Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, CGNH has a market cap of 24046.00. Regarding current trading prices, ARYC is priced at $0.00, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas CGNH's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, ARYC is more volatile compared to CGNH. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs TOMDF Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, TOMDF has a market cap of 14081.00. Regarding current trading prices, ARYC is priced at $0.00, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas TOMDF's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, ARYC is more volatile compared to TOMDF. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs ABMC Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, ABMC has a market cap of 4810.00. Regarding current trading prices, ARYC is priced at $0.00, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas ABMC's P/E ratio is 0.01. In terms of profitability, ARYC's ROE is +0.55%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, ARYC is more volatile compared to ABMC. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs RGDXQ Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, RGDXQ has a market cap of 3880.00. Regarding current trading prices, ARYC is priced at $0.00, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, ARYC and RGDXQ have similar daily volatility (196.04).
ARYC vs GWHP Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, GWHP has a market cap of 1313.00. Regarding current trading prices, ARYC is priced at $0.00, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas GWHP's P/E ratio is -0.00. In terms of profitability, ARYC's ROE is +0.55%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, ARYC is more volatile compared to GWHP. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs CYPS Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, CYPS has a market cap of 811.00. Regarding current trading prices, ARYC is priced at $0.00, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas CYPS's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to CYPS's ROE of N/A. Regarding short-term risk, ARYC is more volatile compared to CYPS. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs ROSGQ Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, ROSGQ has a market cap of 593.00. Regarding current trading prices, ARYC is priced at $0.00, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to ROSGQ's ROE of N/A. Regarding short-term risk, ARYC is more volatile compared to ROSGQ. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs BIOCQ Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, BIOCQ has a market cap of 263.00. Regarding current trading prices, ARYC is priced at $0.00, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas BIOCQ's P/E ratio is -0.00. In terms of profitability, ARYC's ROE is +0.55%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, ARYC is more volatile compared to BIOCQ. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs HTGMQ Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, HTGMQ has a market cap of 221.00. Regarding current trading prices, ARYC is priced at $0.00, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, ARYC is more volatile compared to HTGMQ. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs DMTKQ Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, DMTKQ has a market cap of 35.00. Regarding current trading prices, ARYC is priced at $0.00, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, ARYC is more volatile compared to DMTKQ. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.
ARYC vs OPGX Comparison
ARYC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARYC stands at 79348.00. In comparison, OPGX has a market cap of 17.00. Regarding current trading prices, ARYC is priced at $0.00, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARYC currently has a P/E ratio of N/A, whereas OPGX's P/E ratio is N/A. In terms of profitability, ARYC's ROE is +0.55%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, ARYC is more volatile compared to OPGX. This indicates potentially higher risk in terms of short-term price fluctuations for ARYC.